Search

everythinglearnresearchcommunity

for

Search:↓

AIRE protein, defective in APECED patients, is found in skin and hair cells and interacts with cytokeratin 17.

Ritlecitinib significantly regrows scalp hair in people with alopecia areata.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

Relapsing polychondritis might be linked to alopecia areata due to immune system factors.

Ritlecitinib is safe and may effectively treat alopecia areata.

The mutated hairless gene causes hair loss by acting as a new type of corepressor affecting thyroid hormone receptors.

A specific gene variant is linked to severe insulin resistance and hormone imbalance in a teenage girl.

Alternative treatments are needed when Tofacitinib alone fails for alopecia areata.

Autoimmune gastritis is a common cause of iron deficiency and should be included in diagnostic guidelines.

TNF-α inhibitors may cause complete hair loss in some patients with ankylosing spondylitis.

Hypothyroidism patients with hair loss typically have thinning hair, smaller hair follicles, and normal hair shedding.

CRH promotes fat production in skin cells, affecting conditions like acne.

The antibody 005-C04 blocks prolactin receptors, causing reversible infertility, impaired lactation, and hair regrowth in female mice.

The thyroid nodule was benign, and surgery was successful with a smooth recovery.

Orlistat might block the body's ability to absorb thyroid medication.

TAGX-0003 protected hair follicles and reversed alopecia areata in a mouse model.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

Borderline newborn screening results should be carefully evaluated to prevent delayed diagnosis of thyroid issues.

A woman with undifferentiated connective tissue disease was diagnosed with renal amyloidosis and carpal tunnel syndrome.

Over 45% of patients with alopecia areata benefit from ritlecitinib, mostly within a year.

Alopecia can be caused by multicentric reticulohistiocytosis.

Ritlecitinib is effective and safe for treating severe alopecia areata, showing significant hair regrowth and improved mental health.

TIP39 and PTH2R help control calcium levels and skin cell development.

Th22 cells are essential for Tβ15-induced hair growth in mice.

Inflammation damages sweat ducts, causing sweat gland injury.

HKN-2 antibody targets specific skin and hair cells, showing keratin complexity.

Thyroid disorders include hypothyroidism, causing fatigue and weight gain, and hyperthyroidism, causing weight loss and anxiety.

A new diagnostic model can help better diagnose and understand Alopecia Areata.

People with alopecia areata have higher levels of a heart disease marker than those without hair loss.

Methotrexate can temporarily suppress certain immune responses without killing immune cells, potentially helping treat autoimmune diseases.